COMPOSICION PARA EL TRATAMIENTO DE LA ICTIOSIS QUE UTILIZA LA ANTITRIPSINA

Utilización de la alfa1-antitripsina y de un agente gelificante para la preparación de un medicamento destinado al tratamiento o la prevención de la ictiosis. Compositions containing a protease inhibitor and methods of use and production are described. The compositions contain an effective amount of...

Full description

Saved in:
Bibliographic Details
Main Authors BATHURST, IAN C, PEMBERTON, PHILIP A, BARR, PHILIP J, MAYHEW, JAMES W, ANGEL, ARTURO J, SUNDIN, DAVID J
Format Patent
LanguageSpanish
Published 11.12.2009
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Utilización de la alfa1-antitripsina y de un agente gelificante para la preparación de un medicamento destinado al tratamiento o la prevención de la ictiosis. Compositions containing a protease inhibitor and methods of use and production are described. The compositions contain an effective amount of a protease inhibitor in a carrier or diluent and are used for the treatment of inflammatory or hyperproliferic mucocutaneous disorders. The carrier or diluent is preferably a gelling agent, and the composition is a topical gel formulation containing alpha 1 -antitrypsin in an aqueous liquid or viscous gel formulation.
Bibliography:Application Number: ES20030777001T